Metraipolis › archive › dc_0ca6939b6feb

Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40748728
DOI
10.1093/rheumatology/keaf355
License (as archived)
solo-consultazione
Archived
2026-11-08T02:55:38.508Z
SHA-256 of the archived text
4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328
Stable URL of this page
https://metraipolis.com/documento/dc_0ca6939b6feb

How to cite

Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728 — Europe PMC (en), https://europepmc.org/article/MED/40748728 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ca6939b6feb (Metraipolis archive dc_0ca6939b6feb, sha256 4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328)
BibTeX
@misc{dc0ca6939b6feb,
  title = {Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40748728},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ca6939b6feb; sha256 4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40748728. Agents can read the archived copy with the MCP tool read_document.